var eventsData = [{"Ticker":"NOV","EffectiveDate":"2017-02-08","Type":"RatingUpgrade","Title":"Credit Suisse upgrades NOV to Neutral from Underperform.","DailyReturn":-0.002036,"FiveDayReturnAfter":null,"FiveDayReturnBefore":0.038395},{"Ticker":"NOV","EffectiveDate":"2017-02-07","Type":"RatingNeutral","Title":"Loop Capital initiates coverage on NOV to Hold.","DailyReturn":0.048852,"FiveDayReturnAfter":null,"FiveDayReturnBefore":-0.002401},{"Ticker":"NOV","EffectiveDate":"2017-02-07","Type":"EarningsRevenueBeat","Title":"Before market open, NOV reports 2016 Q4's earning $-0.15 per share and revenue $1692MM. This beats analyst's estimated EPS $-0.28, beats estimated revenue $1620MM.","DailyReturn":0.048852,"FiveDayReturnAfter":null,"FiveDayReturnBefore":-0.002401},{"Ticker":"NOV","EffectiveDate":"2017-01-19","Type":"RatingUpgrade","Title":"Societe Generale upgrades NOV to Buy from Hold.","DailyReturn":0.012827,"FiveDayReturnAfter":0.059648,"FiveDayReturnBefore":-0.009045},{"Ticker":"NOV","EffectiveDate":"2016-12-09","Type":"RatingNeutral","Title":"Johnson Rice downgrades NOV to Hold from Accumulate.","DailyReturn":-0.002508,"FiveDayReturnAfter":-0.004524,"FiveDayReturnBefore":0.059137},{"Ticker":"NOV","EffectiveDate":"2016-12-01","Type":"RatingNeutral","Title":"Seaport Global downgrades NOV to Sell from Accumulate.","DailyReturn":0.006156,"FiveDayReturnAfter":0.052657,"FiveDayReturnBefore":0.028852},{"Ticker":"NOV","EffectiveDate":"2016-11-30","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":0.081331,"FiveDayReturnAfter":0.130596,"FiveDayReturnBefore":-0.051814},{"Ticker":"NOV","EffectiveDate":"2016-11-09","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.032592,"FiveDayReturnAfter":0.12171,"FiveDayReturnBefore":-0.000627},{"Ticker":"NOV","EffectiveDate":"2016-11-07","Type":"RatingUpgrade","Title":"Citigroup upgrades NOV to Neutral from Sell.","DailyReturn":0.011292,"FiveDayReturnAfter":0.044778,"FiveDayReturnBefore":-0.032405},{"Ticker":"NOV","EffectiveDate":"2016-11-07","Type":"RatingUpgrade","Title":"Citigroup upgrades NOV to Neutral from Sell.","DailyReturn":0.011292,"FiveDayReturnAfter":0.044778,"FiveDayReturnBefore":-0.032405},{"Ticker":"NOV","EffectiveDate":"2016-10-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.011062,"FiveDayReturnAfter":-0.124408,"FiveDayReturnBefore":-0.013733},{"Ticker":"NOV","EffectiveDate":"2016-10-26","Type":"EarningsRevenueMiss","Title":"After market close, NOV reports 2016 Q3's earning $-0.34 per share and revenue $1646MM. This misses analyst's estimated EPS $-0.28, misses estimated revenue $1680MM.","DailyReturn":0.011062,"FiveDayReturnAfter":-0.124408,"FiveDayReturnBefore":-0.013733},{"Ticker":"NOV","EffectiveDate":"2016-10-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.011062,"FiveDayReturnAfter":-0.124408,"FiveDayReturnBefore":-0.013733},{"Ticker":"NOV","EffectiveDate":"2016-10-03","Type":"RatingNeutral","Title":"Citigroup downgrades NOV to Sell from Neutral. Target Price is $30; previously $37.","DailyReturn":-0.015787,"FiveDayReturnAfter":0.002718,"FiveDayReturnBefore":0.080746},{"Ticker":"NOV","EffectiveDate":"2016-09-30","Type":"RatingNeutral","Title":"Loop Capital initiates coverage on NOV to Hold. Target Price is $37.","DailyReturn":-0.003256,"FiveDayReturnAfter":0.004061,"FiveDayReturnBefore":0.069651},{"Ticker":"NOV","EffectiveDate":"2016-09-14","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":-0.022094,"FiveDayReturnAfter":-0.034799,"FiveDayReturnBefore":-0.035332},{"Ticker":"NOV","EffectiveDate":"2016-09-12","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Neutral. Target Price is $37; previously $36.","DailyReturn":0.027753,"FiveDayReturnAfter":-0.007273,"FiveDayReturnBefore":0.003322},{"Ticker":"NOV","EffectiveDate":"2016-07-29","Type":"RatingUpgrade","Title":"Johnson Rice upgrades NOV to Accumulate from Hold.","DailyReturn":0.009675,"FiveDayReturnAfter":0.016098,"FiveDayReturnBefore":-0.025272},{"Ticker":"NOV","EffectiveDate":"2016-07-28","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NOV reports 2016 Q2's earning $-0.3 per share and revenue $1724MM. This beats analyst's estimated EPS $-0.32, misses estimated revenue $1790MM.","DailyReturn":0.024624,"FiveDayReturnAfter":0.043491,"FiveDayReturnBefore":-0.052333},{"Ticker":"NOV","EffectiveDate":"2016-07-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.024624,"FiveDayReturnAfter":0.043491,"FiveDayReturnBefore":-0.052333},{"Ticker":"NOV","EffectiveDate":"2016-07-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.024624,"FiveDayReturnAfter":0.043491,"FiveDayReturnBefore":-0.052333},{"Ticker":"NOV","EffectiveDate":"2016-07-11","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Hold. Target Price is $33; previously $30.","DailyReturn":-0.012274,"FiveDayReturnAfter":0.034679,"FiveDayReturnBefore":-0.032008},{"Ticker":"NOV","EffectiveDate":"2016-06-13","Type":"RatingNeutral","Title":"Bank of America assumes NOV to Underperform.","DailyReturn":-0.012561,"FiveDayReturnAfter":0.004272,"FiveDayReturnBefore":0.08904},{"Ticker":"NOV","EffectiveDate":"2016-06-08","Type":"Dividend","Title":"The Firm pays dividend $0.05","DailyReturn":0.021547,"FiveDayReturnAfter":-0.058591,"FiveDayReturnBefore":0.095448},{"Ticker":"NOV","EffectiveDate":"2016-05-18","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.041743,"FiveDayReturnAfter":-0.041368,"FiveDayReturnBefore":0.032831},{"Ticker":"NOV","EffectiveDate":"2016-05-04","Type":"RatingNeutral","Title":"Societe Generale downgrades NOV to Sell from Hold.","DailyReturn":-0.038771,"FiveDayReturnAfter":-0.091985,"FiveDayReturnBefore":0.170218},{"Ticker":"NOV","EffectiveDate":"2016-04-28","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NOV reports 2016 Q1's earning $-0.06 per share and revenue $2189MM. This beats analyst's estimated EPS $-0.07, misses estimated revenue $2260MM.","DailyReturn":0.044164,"FiveDayReturnAfter":0.054332,"FiveDayReturnBefore":0.099419},{"Ticker":"NOV","EffectiveDate":"2016-04-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.044164,"FiveDayReturnAfter":0.054332,"FiveDayReturnBefore":0.099419},{"Ticker":"NOV","EffectiveDate":"2016-04-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.044164,"FiveDayReturnAfter":0.054332,"FiveDayReturnBefore":0.099419},{"Ticker":"NOV","EffectiveDate":"2016-04-27","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades NOV to Overweight from Underweight. Target Price is $45; previously $39.","DailyReturn":0.079333,"FiveDayReturnAfter":0.170218,"FiveDayReturnBefore":0.00512},{"Ticker":"NOV","EffectiveDate":"2016-04-20","Type":"RatingNeutral","Title":"Barclays downgrades NOV to Equal-weight from Overweight. Target Price is $33.","DailyReturn":-0.017796,"FiveDayReturnAfter":0.00512,"FiveDayReturnBefore":0.048739},{"Ticker":"NOV","EffectiveDate":"2016-04-19","Type":"RatingNeutral","Title":"Morgan Stanley maintains NOV to Underweight. Target Price is $39; previously $35.","DailyReturn":0.03397,"FiveDayReturnAfter":0.036822,"FiveDayReturnBefore":0.033829},{"Ticker":"NOV","EffectiveDate":"2016-04-07","Type":"RatingNeutral","Title":"Nomura initiates coverage on NOV to Neutral. Target Price is $29.","DailyReturn":-0.022245,"FiveDayReturnAfter":-0.000341,"FiveDayReturnBefore":-0.062353},{"Ticker":"NOV","EffectiveDate":"2016-04-05","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.018925,"FiveDayReturnAfter":-0.079816,"FiveDayReturnBefore":-0.062234},{"Ticker":"NOV","EffectiveDate":"2016-04-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.018925,"FiveDayReturnAfter":-0.079816,"FiveDayReturnBefore":-0.062234},{"Ticker":"NOV","EffectiveDate":"2016-03-09","Type":"RatingNeutral","Title":"Susquehanna maintains NOV to Neutral. Target Price is $30; previously $27.","DailyReturn":0.010954,"FiveDayReturnAfter":0.064559,"FiveDayReturnBefore":0.06526},{"Ticker":"NOV","EffectiveDate":"2016-03-09","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":0.010954,"FiveDayReturnAfter":0.064559,"FiveDayReturnBefore":0.06526},{"Ticker":"NOV","EffectiveDate":"2016-02-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.014311,"FiveDayReturnAfter":0.029577,"FiveDayReturnBefore":0.020809},{"Ticker":"NOV","EffectiveDate":"2016-02-24","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.014311,"FiveDayReturnAfter":0.029577,"FiveDayReturnBefore":0.020809},{"Ticker":"NOV","EffectiveDate":"2016-02-04","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Hold. Target Price is $27; previously $34.","DailyReturn":0.020714,"FiveDayReturnAfter":-0.047915,"FiveDayReturnBefore":-0.105002},{"Ticker":"NOV","EffectiveDate":"2016-02-04","Type":"RatingNeutral","Title":"Barclays maintains NOV to Overweight. Target Price is $33; previously $44.","DailyReturn":0.020714,"FiveDayReturnAfter":-0.047915,"FiveDayReturnBefore":-0.105002},{"Ticker":"NOV","EffectiveDate":"2016-02-04","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Neutral. Target Price is $30; previously $32.","DailyReturn":0.020714,"FiveDayReturnAfter":-0.047915,"FiveDayReturnBefore":-0.105002},{"Ticker":"NOV","EffectiveDate":"2016-02-03","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.087056,"FiveDayReturnAfter":-0.10692,"FiveDayReturnBefore":0.007858},{"Ticker":"NOV","EffectiveDate":"2016-02-03","Type":"EarningsRevenueMiss","Title":"Before market open, NOV reports 2015 Q4's earning $0.4 per share and revenue $2722MM. This misses analyst's estimated EPS $0.44, misses estimated revenue $3030MM.","DailyReturn":-0.087056,"FiveDayReturnAfter":-0.10692,"FiveDayReturnBefore":0.007858},{"Ticker":"NOV","EffectiveDate":"2016-02-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.087056,"FiveDayReturnAfter":-0.10692,"FiveDayReturnBefore":0.007858},{"Ticker":"NOV","EffectiveDate":"2016-01-12","Type":"RatingNeutral","Title":"Oppenheimer initiates coverage on NOV to Perform.","DailyReturn":0.016027,"FiveDayReturnAfter":-0.014122,"FiveDayReturnBefore":-0.144614},{"Ticker":"NOV","EffectiveDate":"2016-01-05","Type":"RatingNeutral","Title":"GMP Securities initiates coverage on NOV to Hold. Target Price is $34.","DailyReturn":-0.028604,"FiveDayReturnAfter":-0.144614,"FiveDayReturnBefore":-0.005476},{"Ticker":"NOV","EffectiveDate":"2016-01-05","Type":"RatingNeutral","Title":"KeyBanc downgrades NOV to Sector Weight from Overweight.","DailyReturn":-0.028604,"FiveDayReturnAfter":-0.144614,"FiveDayReturnBefore":-0.005476},{"Ticker":"NOV","EffectiveDate":"2015-12-28","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.018678,"FiveDayReturnAfter":-0.005476,"FiveDayReturnBefore":0.033009},{"Ticker":"NOV","EffectiveDate":"2015-12-18","Type":"RatingNeutral","Title":"William Blair downgrades NOV to Market Perform from Outperform.","DailyReturn":-0.01188,"FiveDayReturnAfter":0.033009,"FiveDayReturnBefore":-0.003854},{"Ticker":"NOV","EffectiveDate":"2015-12-14","Type":"RatingNeutral","Title":"KLR Group initiates coverage on NOV to Buy. Target Price is $52.","DailyReturn":0.008111,"FiveDayReturnAfter":-0.000601,"FiveDayReturnBefore":-0.094518},{"Ticker":"NOV","EffectiveDate":"2015-12-11","Type":"RatingUpgrade","Title":"Citigroup upgrades NOV to Neutral from Sell. Target Price is $34.","DailyReturn":-0.015089,"FiveDayReturnAfter":-0.003854,"FiveDayReturnBefore":-0.091808},{"Ticker":"NOV","EffectiveDate":"2015-12-02","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":-0.004831,"FiveDayReturnAfter":-0.106376,"FiveDayReturnBefore":0.010394},{"Ticker":"NOV","EffectiveDate":"2015-11-30","Type":"RatingUpgrade","Title":"Guggenheim upgrades NOV to Buy from Neutral.","DailyReturn":-0.000268,"FiveDayReturnAfter":-0.008288,"FiveDayReturnBefore":-0.006671},{"Ticker":"NOV","EffectiveDate":"2015-11-02","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.032147,"FiveDayReturnAfter":0.055549,"FiveDayReturnBefore":-0.03061},{"Ticker":"NOV","EffectiveDate":"2015-11-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.032147,"FiveDayReturnAfter":0.055549,"FiveDayReturnBefore":-0.03061},{"Ticker":"NOV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"Barclays maintains NOV to Overweight. Target Price is $44; previously $48.","DailyReturn":-0.007625,"FiveDayReturnAfter":0.082805,"FiveDayReturnBefore":-0.065355},{"Ticker":"NOV","EffectiveDate":"2015-10-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.021419,"FiveDayReturnAfter":0.105251,"FiveDayReturnBefore":-0.092145},{"Ticker":"NOV","EffectiveDate":"2015-10-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.021419,"FiveDayReturnAfter":0.105251,"FiveDayReturnBefore":-0.092145},{"Ticker":"NOV","EffectiveDate":"2015-10-05","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Sell. Target Price is $32; previously $37.","DailyReturn":0.04862,"FiveDayReturnAfter":0.069781,"FiveDayReturnBefore":0.015894},{"Ticker":"NOV","EffectiveDate":"2015-09-11","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.015541,"FiveDayReturnAfter":0.00812,"FiveDayReturnBefore":-0.028812},{"Ticker":"NOV","EffectiveDate":"2015-09-09","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":-0.033865,"FiveDayReturnAfter":-0.03755,"FiveDayReturnBefore":-0.041236},{"Ticker":"NOV","EffectiveDate":"2015-09-04","Type":"RatingNeutral","Title":"Credit Suisse maintains NOV to Underperform. Target Price is $33; previously $39.","DailyReturn":-0.012936,"FiveDayReturnAfter":-0.047163,"FiveDayReturnBefore":-0.009474},{"Ticker":"NOV","EffectiveDate":"2015-08-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.016327,"FiveDayReturnAfter":-0.029482,"FiveDayReturnBefore":0.112725},{"Ticker":"NOV","EffectiveDate":"2015-08-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.016327,"FiveDayReturnAfter":-0.029482,"FiveDayReturnBefore":0.112725},{"Ticker":"NOV","EffectiveDate":"2015-08-26","Type":"RatingUpgrade","Title":"JP Morgan upgrades NOV to Neutral from Underweight.","DailyReturn":0.04498,"FiveDayReturnAfter":0.101741,"FiveDayReturnBefore":-0.061775},{"Ticker":"NOV","EffectiveDate":"2015-08-05","Type":"RatingNeutral","Title":"Argus Research downgrades NOV to Hold from Buy.","DailyReturn":-0.006642,"FiveDayReturnAfter":-0.003944,"FiveDayReturnBefore":-0.054572},{"Ticker":"NOV","EffectiveDate":"2015-07-31","Type":"RatingNeutral","Title":"Bank of America downgrades NOV to Neutral from Buy.","DailyReturn":-0.029039,"FiveDayReturnAfter":-0.066462,"FiveDayReturnBefore":0.010892},{"Ticker":"NOV","EffectiveDate":"2015-07-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.030732,"FiveDayReturnAfter":-0.016461,"FiveDayReturnBefore":-0.034917},{"Ticker":"NOV","EffectiveDate":"2015-07-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.030732,"FiveDayReturnAfter":-0.016461,"FiveDayReturnBefore":-0.034917},{"Ticker":"NOV","EffectiveDate":"2015-07-17","Type":"RatingNeutral","Title":"UBS downgrades NOV to Sell.","DailyReturn":-0.011037,"FiveDayReturnAfter":-0.013193,"FiveDayReturnBefore":-0.024755},{"Ticker":"NOV","EffectiveDate":"2015-07-08","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Sell. Target Price is $41; previously $45.","DailyReturn":-0.02236,"FiveDayReturnAfter":0.007718,"FiveDayReturnBefore":-0.072574},{"Ticker":"NOV","EffectiveDate":"2015-06-10","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":0.037099,"FiveDayReturnAfter":0.026828,"FiveDayReturnBefore":-0.046898},{"Ticker":"NOV","EffectiveDate":"2015-05-29","Type":"RatingNeutral","Title":"JP Morgan initiates coverage on NOV to Underweight. Target Price is $40.","DailyReturn":-0.014031,"FiveDayReturnAfter":-0.025579,"FiveDayReturnBefore":-0.005596},{"Ticker":"NOV","EffectiveDate":"2015-05-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.00777,"FiveDayReturnAfter":-0.029971,"FiveDayReturnBefore":-0.073386},{"Ticker":"NOV","EffectiveDate":"2015-05-12","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.002922,"FiveDayReturnAfter":-0.002927,"FiveDayReturnBefore":-0.064319},{"Ticker":"NOV","EffectiveDate":"2015-05-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.002922,"FiveDayReturnAfter":-0.002927,"FiveDayReturnBefore":-0.064319},{"Ticker":"NOV","EffectiveDate":"2015-05-12","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.002922,"FiveDayReturnAfter":-0.002927,"FiveDayReturnBefore":-0.064319},{"Ticker":"NOV","EffectiveDate":"2015-05-11","Type":"RatingNeutral","Title":"Citigroup downgrades NOV to Sell from Neutral. Target Price is $45; previously $53.","DailyReturn":-0.035694,"FiveDayReturnAfter":-0.037517,"FiveDayReturnBefore":-0.027789},{"Ticker":"NOV","EffectiveDate":"2015-04-29","Type":"RatingNeutral","Title":"Morgan Stanley downgrades NOV to Underweight from Equal-Weight. Target Price is $53.","DailyReturn":0.019064,"FiveDayReturnAfter":0.064684,"FiveDayReturnBefore":-0.022846},{"Ticker":"NOV","EffectiveDate":"2015-04-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.050466,"FiveDayReturnAfter":0.000915,"FiveDayReturnBefore":-0.006199},{"Ticker":"NOV","EffectiveDate":"2015-04-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.050466,"FiveDayReturnAfter":0.000915,"FiveDayReturnBefore":-0.006199},{"Ticker":"NOV","EffectiveDate":"2015-04-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.034527,"FiveDayReturnAfter":-0.006199,"FiveDayReturnBefore":0.034196},{"Ticker":"NOV","EffectiveDate":"2015-04-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.034527,"FiveDayReturnAfter":-0.006199,"FiveDayReturnBefore":0.034196},{"Ticker":"NOV","EffectiveDate":"2015-03-11","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":-0.001195,"FiveDayReturnAfter":-0.056527,"FiveDayReturnBefore":-0.071567},{"Ticker":"NOV","EffectiveDate":"2015-02-18","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on NOV to Underperform. Target Price is $52.","DailyReturn":0.012879,"FiveDayReturnAfter":-0.008196,"FiveDayReturnBefore":0.043562},{"Ticker":"NOV","EffectiveDate":"2015-02-04","Type":"RatingNeutral","Title":"Clarksons Platou downgrades NOV to Hold from Buy.","DailyReturn":-0.032359,"FiveDayReturnAfter":-0.032511,"FiveDayReturnBefore":-0.064793},{"Ticker":"NOV","EffectiveDate":"2015-02-04","Type":"RatingNeutral","Title":"Sterne Agee downgrades NOV to Neutral from Buy.","DailyReturn":-0.032359,"FiveDayReturnAfter":-0.032511,"FiveDayReturnBefore":-0.064793},{"Ticker":"NOV","EffectiveDate":"2015-02-04","Type":"RatingNeutral","Title":"Susquehanna downgrades NOV to Neutral from Positive.","DailyReturn":-0.032359,"FiveDayReturnAfter":-0.032511,"FiveDayReturnBefore":-0.064793},{"Ticker":"NOV","EffectiveDate":"2015-02-04","Type":"RatingNeutral","Title":"UBS maintains NOV to Neutral. Target Price is $58; previously $72.","DailyReturn":-0.032359,"FiveDayReturnAfter":-0.032511,"FiveDayReturnBefore":-0.064793},{"Ticker":"NOV","EffectiveDate":"2015-02-03","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.040965,"FiveDayReturnAfter":-0.066159,"FiveDayReturnBefore":-0.023658},{"Ticker":"NOV","EffectiveDate":"2015-02-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.040965,"FiveDayReturnAfter":-0.066159,"FiveDayReturnBefore":-0.023658},{"Ticker":"NOV","EffectiveDate":"2015-02-02","Type":"RatingNeutral","Title":"Raymond James downgrades NOV to Outperform from Strong Buy. Target Price is $61; previously $70.","DailyReturn":0.03601,"FiveDayReturnAfter":-0.056692,"FiveDayReturnBefore":-0.048764},{"Ticker":"NOV","EffectiveDate":"2015-02-02","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Hold. Target Price is $59; previously $73.","DailyReturn":0.03601,"FiveDayReturnAfter":-0.056692,"FiveDayReturnBefore":-0.048764},{"Ticker":"NOV","EffectiveDate":"2015-01-28","Type":"RatingNeutral","Title":"Credit Suisse downgrades NOV to Underperform from Neutral. Target Price is $43; previously $60.","DailyReturn":-0.07227,"FiveDayReturnAfter":-0.064793,"FiveDayReturnBefore":-0.010516},{"Ticker":"NOV","EffectiveDate":"2015-01-26","Type":"RatingNeutral","Title":"Guggenheim downgrades NOV to Neutral from Buy; previously $80.","DailyReturn":0.010324,"FiveDayReturnAfter":-0.048764,"FiveDayReturnBefore":0.00632},{"Ticker":"NOV","EffectiveDate":"2015-01-09","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Neutral. Target Price is $62; previously $76.","DailyReturn":-0.027503,"FiveDayReturnAfter":-0.113725,"FiveDayReturnBefore":-0.029423},{"Ticker":"NOV","EffectiveDate":"2015-01-06","Type":"RatingNeutral","Title":"Societe Generale downgrades NOV to Hold from Buy.","DailyReturn":-0.01232,"FiveDayReturnAfter":-0.064433,"FiveDayReturnBefore":-0.065038},{"Ticker":"NOV","EffectiveDate":"2014-12-23","Type":"RatingUpgrade","Title":"Seaport Global upgrades NOV to Accumulate from Neutral. Target Price is $74.","DailyReturn":0.003018,"FiveDayReturnAfter":-0.000454,"FiveDayReturnBefore":0.067883},{"Ticker":"NOV","EffectiveDate":"2014-12-03","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":0.021772,"FiveDayReturnAfter":-0.018464,"FiveDayReturnBefore":-0.099262},{"Ticker":"NOV","EffectiveDate":"2014-11-24","Type":"RatingNeutral","Title":"Credit Suisse maintains NOV to Neutral. Target Price is $75; previously $77.","DailyReturn":-0.003657,"FiveDayReturnAfter":-0.105031,"FiveDayReturnBefore":0.034173},{"Ticker":"NOV","EffectiveDate":"2014-11-24","Type":"RatingNeutral","Title":"Credit Suisse maintains NOV to Neutral. Target Price is $75; previously $77.","DailyReturn":-0.003657,"FiveDayReturnAfter":-0.105031,"FiveDayReturnBefore":0.034173},{"Ticker":"NOV","EffectiveDate":"2014-11-20","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.01217,"FiveDayReturnAfter":-0.002801,"FiveDayReturnBefore":-0.020902},{"Ticker":"NOV","EffectiveDate":"2014-11-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.01217,"FiveDayReturnAfter":-0.002801,"FiveDayReturnBefore":-0.020902},{"Ticker":"NOV","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"FBR Capital maintains NOV to Outperform. Target Price is $88; previously $100.","DailyReturn":0.035001,"FiveDayReturnAfter":0.055694,"FiveDayReturnBefore":-0.055423},{"Ticker":"NOV","EffectiveDate":"2014-11-03","Type":"RatingNeutral","Title":"Credit Suisse downgrades NOV to Neutral from Outperform. Target Price is $77; previously $95.","DailyReturn":-0.026432,"FiveDayReturnAfter":0.008497,"FiveDayReturnBefore":-0.012043},{"Ticker":"NOV","EffectiveDate":"2014-11-03","Type":"RatingNeutral","Title":"Cowen & Co. downgrades NOV to Market Perform from Outperform.","DailyReturn":-0.026432,"FiveDayReturnAfter":0.008497,"FiveDayReturnBefore":-0.012043},{"Ticker":"NOV","EffectiveDate":"2014-10-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.027087,"FiveDayReturnAfter":-0.01622,"FiveDayReturnBefore":0.017895},{"Ticker":"NOV","EffectiveDate":"2014-10-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.027087,"FiveDayReturnAfter":-0.01622,"FiveDayReturnBefore":0.017895},{"Ticker":"NOV","EffectiveDate":"2014-10-16","Type":"RatingNeutral","Title":"ISI Group initiates coverage on NOV to Buy. Target Price is $95.","DailyReturn":0.017722,"FiveDayReturnAfter":0.020793,"FiveDayReturnBefore":-0.055052},{"Ticker":"NOV","EffectiveDate":"2014-10-08","Type":"RatingNeutral","Title":"HSBC downgrades NOV to Neutral from Overweight. Target Price is $80; previously $89.22.","DailyReturn":0.003257,"FiveDayReturnAfter":-0.073033,"FiveDayReturnBefore":-0.03218},{"Ticker":"NOV","EffectiveDate":"2014-10-02","Type":"RatingUpgrade","Title":"Standpoint upgrades NOV to Buy from Hold.","DailyReturn":-0.004695,"FiveDayReturnAfter":-0.008216,"FiveDayReturnBefore":-0.056339},{"Ticker":"NOV","EffectiveDate":"2014-09-30","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.025608,"FiveDayReturnAfter":-0.06016,"FiveDayReturnBefore":-0.007653},{"Ticker":"NOV","EffectiveDate":"2014-09-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.025608,"FiveDayReturnAfter":-0.06016,"FiveDayReturnBefore":-0.007653},{"Ticker":"NOV","EffectiveDate":"2014-09-24","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on NOV to Market Perform.","DailyReturn":0.000508,"FiveDayReturnAfter":-0.035119,"FiveDayReturnBefore":-0.043811},{"Ticker":"NOV","EffectiveDate":"2014-09-10","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":0.00246,"FiveDayReturnAfter":0.012955,"FiveDayReturnBefore":-0.034622},{"Ticker":"NOV","EffectiveDate":"2014-08-18","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.004628,"FiveDayReturnAfter":0.022758,"FiveDayReturnBefore":-0.002433},{"Ticker":"NOV","EffectiveDate":"2014-08-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.004628,"FiveDayReturnAfter":0.022758,"FiveDayReturnBefore":-0.002433},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.017636,"FiveDayReturnAfter":0.019512,"FiveDayReturnBefore":0.002558},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.017636,"FiveDayReturnAfter":0.019512,"FiveDayReturnBefore":0.002558},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.017636,"FiveDayReturnAfter":0.019512,"FiveDayReturnBefore":0.002558},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.017636,"FiveDayReturnAfter":0.019512,"FiveDayReturnBefore":0.002558},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.017636,"FiveDayReturnAfter":0.019512,"FiveDayReturnBefore":0.002558},{"Ticker":"NOV","EffectiveDate":"2014-08-14","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.017636,"FiveDayReturnAfter":0.019512,"FiveDayReturnBefore":0.002558},{"Ticker":"NOV","EffectiveDate":"2014-08-01","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.000617,"FiveDayReturnAfter":0.007377,"FiveDayReturnBefore":-0.052987},{"Ticker":"NOV","EffectiveDate":"2014-08-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.000617,"FiveDayReturnAfter":0.007377,"FiveDayReturnBefore":-0.052987},{"Ticker":"NOV","EffectiveDate":"2014-07-30","Type":"RatingNeutral","Title":"Credit Suisse maintains NOV to Outperform. Target Price is $95; previously $90.","DailyReturn":-0.020141,"FiveDayReturnAfter":-0.022428,"FiveDayReturnBefore":-0.030927},{"Ticker":"NOV","EffectiveDate":"2014-07-30","Type":"RatingNeutral","Title":"Raymond James maintains NOV to Outperform. Target Price is $98; previously $95.","DailyReturn":-0.020141,"FiveDayReturnAfter":-0.022428,"FiveDayReturnBefore":-0.030927},{"Ticker":"NOV","EffectiveDate":"2014-07-30","Type":"RatingNeutral","Title":"Jefferies downgrades NOV to Hold from Buy. Target Price is $91; previously $85.62.","DailyReturn":-0.020141,"FiveDayReturnAfter":-0.022428,"FiveDayReturnBefore":-0.030927},{"Ticker":"NOV","EffectiveDate":"2014-07-30","Type":"RatingNeutral","Title":"iBERIA Capital Partners downgrades NOV to Sector Perform from Outperform. Target Price is $88; previously $79.31.","DailyReturn":-0.020141,"FiveDayReturnAfter":-0.022428,"FiveDayReturnBefore":-0.030927},{"Ticker":"NOV","EffectiveDate":"2014-07-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.01523,"FiveDayReturnAfter":-0.021841,"FiveDayReturnBefore":-0.010336},{"Ticker":"NOV","EffectiveDate":"2014-07-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.01523,"FiveDayReturnAfter":-0.021841,"FiveDayReturnBefore":-0.010336},{"Ticker":"NOV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"Standpoint Research downgrades NOV to Hold from Buy.","DailyReturn":-0.008471,"FiveDayReturnAfter":-0.053016,"FiveDayReturnBefore":0.00956},{"Ticker":"NOV","EffectiveDate":"2014-06-25","Type":"RatingNeutral","Title":"Gabelli & Co. initiates coverage on NOV to Buy.","DailyReturn":0.015841,"FiveDayReturnAfter":0.035447,"FiveDayReturnBefore":0.020578},{"Ticker":"NOV","EffectiveDate":"2014-06-18","Type":"RatingNeutral","Title":"JP Morgan maintains NOV to Overweight. Target Price is $87; previously $94.","DailyReturn":0.000642,"FiveDayReturnAfter":0.020578,"FiveDayReturnBefore":-0.001025},{"Ticker":"NOV","EffectiveDate":"2014-06-12","Type":"RatingUpgrade","Title":"Societe Generale upgrades NOV to Buy from Hold.","DailyReturn":0.008903,"FiveDayReturnAfter":0.020605,"FiveDayReturnBefore":0.006796},{"Ticker":"NOV","EffectiveDate":"2014-06-11","Type":"Dividend","Title":"The Firm pays dividend $0.46","DailyReturn":-0.020769,"FiveDayReturnAfter":-0.001025,"FiveDayReturnBefore":0.031592},{"Ticker":"NOV","EffectiveDate":"2014-06-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.005124,"FiveDayReturnAfter":0.003059,"FiveDayReturnBefore":0.050848},{"Ticker":"NOV","EffectiveDate":"2014-06-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.005124,"FiveDayReturnAfter":0.003059,"FiveDayReturnBefore":0.050848},{"Ticker":"NOV","EffectiveDate":"2014-06-05","Type":"RatingNeutral","Title":"Raymond James maintains NOV to Outperform. Target Price is $85; previously $90.","DailyReturn":-0.000786,"FiveDayReturnAfter":0.006796,"FiveDayReturnBefore":0.033132},{"Ticker":"NOV","EffectiveDate":"2014-06-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000786,"FiveDayReturnAfter":0.006796,"FiveDayReturnBefore":0.033132},{"Ticker":"NOV","EffectiveDate":"2014-06-05","Type":"RatingNeutral","Title":"Credit Suisse assumes NOV to Outperform. Target Price is $90.","DailyReturn":-0.000786,"FiveDayReturnAfter":0.006796,"FiveDayReturnBefore":0.033132},{"Ticker":"NOV","EffectiveDate":"2014-06-05","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":-0.000786,"FiveDayReturnAfter":0.006796,"FiveDayReturnBefore":0.033132},{"Ticker":"NOV","EffectiveDate":"2014-05-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.002558,"FiveDayReturnAfter":0.029784,"FiveDayReturnBefore":-0.003404},{"Ticker":"NOV","EffectiveDate":"2014-05-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.002558,"FiveDayReturnAfter":0.029784,"FiveDayReturnBefore":-0.003404},{"Ticker":"NOV","EffectiveDate":"2014-05-30","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.002558,"FiveDayReturnAfter":0.029784,"FiveDayReturnBefore":-0.003404},{"Ticker":"NOV","EffectiveDate":"2014-05-14","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.003689,"FiveDayReturnAfter":0.009057,"FiveDayReturnBefore":0.015613},{"Ticker":"NOV","EffectiveDate":"2014-05-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.005124,"FiveDayReturnAfter":0.020045,"FiveDayReturnBefore":0.007653},{"Ticker":"NOV","EffectiveDate":"2014-05-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.005124,"FiveDayReturnAfter":0.020045,"FiveDayReturnBefore":0.007653},{"Ticker":"NOV","EffectiveDate":"2014-05-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.003438,"FiveDayReturnAfter":0.027009,"FiveDayReturnBefore":-0.051133},{"Ticker":"NOV","EffectiveDate":"2014-05-01","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.003438,"FiveDayReturnAfter":0.027009,"FiveDayReturnBefore":-0.051133},{"Ticker":"NOV","EffectiveDate":"2014-04-29","Type":"RatingNeutral","Title":"Seaport Global downgrades NOV to Neutral from Buy. Target Price is $80; previously $90.","DailyReturn":0.010348,"FiveDayReturnAfter":0.032702,"FiveDayReturnBefore":-0.064246},{"Ticker":"NOV","EffectiveDate":"2014-04-29","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Buy. Target Price is $96; previously $101.","DailyReturn":0.010348,"FiveDayReturnAfter":0.032702,"FiveDayReturnBefore":-0.064246},{"Ticker":"NOV","EffectiveDate":"2014-04-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.073799,"FiveDayReturnAfter":-0.049989,"FiveDayReturnBefore":0.013268},{"Ticker":"NOV","EffectiveDate":"2014-04-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.073799,"FiveDayReturnAfter":-0.049989,"FiveDayReturnBefore":0.013268},{"Ticker":"NOV","EffectiveDate":"2014-04-15","Type":"RatingNeutral","Title":"Bank of America maintains NOV to Buy. Target Price is $85; previously $93.","DailyReturn":0.015093,"FiveDayReturnAfter":0.033639,"FiveDayReturnBefore":0.029614},{"Ticker":"NOV","EffectiveDate":"2014-04-08","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.012048,"FiveDayReturnAfter":0.029614,"FiveDayReturnBefore":-0.008771},{"Ticker":"NOV","EffectiveDate":"2014-04-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.012048,"FiveDayReturnAfter":0.029614,"FiveDayReturnBefore":-0.008771},{"Ticker":"NOV","EffectiveDate":"2014-04-04","Type":"RatingUpgrade","Title":"Standpoint Research upgrades NOV to Buy from Hold.","DailyReturn":0.010235,"FiveDayReturnAfter":0.005741,"FiveDayReturnBefore":0.02763},{"Ticker":"NOV","EffectiveDate":"2014-03-17","Type":"RatingNeutral","Title":"Goldman Sachs downgrades NOV to Neutral from Buy.","DailyReturn":-0.007105,"FiveDayReturnAfter":-0.001743,"FiveDayReturnBefore":-0.054732},{"Ticker":"NOV","EffectiveDate":"2014-03-13","Type":"RatingNeutral","Title":"ISI Group downgrades NOV to Neutral from Buy.","DailyReturn":-0.027551,"FiveDayReturnAfter":-0.043893,"FiveDayReturnBefore":0.001138},{"Ticker":"NOV","EffectiveDate":"2014-03-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.006554,"FiveDayReturnAfter":-0.046423,"FiveDayReturnBefore":0.003078},{"Ticker":"NOV","EffectiveDate":"2014-03-12","Type":"Dividend","Title":"The Firm pays dividend $0.23445","DailyReturn":-0.006554,"FiveDayReturnAfter":-0.046423,"FiveDayReturnBefore":0.003078},{"Ticker":"NOV","EffectiveDate":"2014-03-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.006554,"FiveDayReturnAfter":-0.046423,"FiveDayReturnBefore":0.003078},{"Ticker":"NOV","EffectiveDate":"2014-02-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.004843,"FiveDayReturnAfter":0.04137,"FiveDayReturnBefore":-0.028119},{"Ticker":"NOV","EffectiveDate":"2014-02-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.004843,"FiveDayReturnAfter":0.04137,"FiveDayReturnBefore":-0.028119},{"Ticker":"NOV","EffectiveDate":"2014-01-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.018466,"FiveDayReturnAfter":0.005551,"FiveDayReturnBefore":-0.032986},{"Ticker":"NOV","EffectiveDate":"2014-01-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.018466,"FiveDayReturnAfter":0.005551,"FiveDayReturnBefore":-0.032986},{"Ticker":"NOV","EffectiveDate":"2014-01-08","Type":"RatingNeutral","Title":"RBC Capital downgrades NOV to Sector Perform from Outperform. Target Price is $86.","DailyReturn":-0.020549,"FiveDayReturnAfter":-0.028983,"FiveDayReturnBefore":0.014259},{"Ticker":"NOV","EffectiveDate":"2014-01-08","Type":"RatingNeutral","Title":"RBC Capital downgrades NOV to Sector Perform from Outperform. Target Price is $86.","DailyReturn":-0.020549,"FiveDayReturnAfter":-0.028983,"FiveDayReturnBefore":0.014259},{"Ticker":"NOV","EffectiveDate":"2013-12-04","Type":"Dividend","Title":"The Firm pays dividend $0.23445","DailyReturn":-0.006192,"FiveDayReturnAfter":-0.03988,"FiveDayReturnBefore":0.000121},{"Ticker":"NOV","EffectiveDate":"2013-11-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.012551,"FiveDayReturnAfter":-0.023829,"FiveDayReturnBefore":-0.007621},{"Ticker":"NOV","EffectiveDate":"2013-11-25","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.012551,"FiveDayReturnAfter":-0.023829,"FiveDayReturnBefore":-0.007621},{"Ticker":"NOV","EffectiveDate":"2013-11-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.013832,"FiveDayReturnAfter":0.011341,"FiveDayReturnBefore":0.012452},{"Ticker":"NOV","EffectiveDate":"2013-11-14","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.013832,"FiveDayReturnAfter":0.011341,"FiveDayReturnBefore":0.012452},{"Ticker":"NOV","EffectiveDate":"2013-10-25","Type":"EarningsRevenueBeat","Title":"Before market open, NOV reports 2013 Q3's earning $1.34 per share and revenue $5690MM. This beats analyst's estimated EPS $1.32, beats estimated revenue $5680MM.","DailyReturn":0.045368,"FiveDayReturnAfter":0.025576,"FiveDayReturnBefore":-0.023234},{"Ticker":"NOV","EffectiveDate":"2013-10-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.045368,"FiveDayReturnAfter":0.025576,"FiveDayReturnBefore":-0.023234},{"Ticker":"NOV","EffectiveDate":"2013-10-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.045368,"FiveDayReturnAfter":0.025576,"FiveDayReturnBefore":-0.023234},{"Ticker":"NOV","EffectiveDate":"2013-10-15","Type":"RatingNeutral","Title":"Baird initiates coverage on NOV to Neutral. Target Price is $82.","DailyReturn":-0.001623,"FiveDayReturnAfter":0.022106,"FiveDayReturnBefore":0.019163},{"Ticker":"NOV","EffectiveDate":"2013-10-07","Type":"RatingNeutral","Title":"Clarksons Platou initiates coverage on NOV to Outperform. Target Price is $96.","DailyReturn":-0.012321,"FiveDayReturnAfter":-0.00277,"FiveDayReturnBefore":0.019423},{"Ticker":"NOV","EffectiveDate":"2013-09-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.002293,"FiveDayReturnAfter":-0.00498,"FiveDayReturnBefore":-0.002925},{"Ticker":"NOV","EffectiveDate":"2013-09-24","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.002293,"FiveDayReturnAfter":-0.00498,"FiveDayReturnBefore":-0.002925},{"Ticker":"NOV","EffectiveDate":"2013-09-16","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Buy. Target Price is $91; previously $84.","DailyReturn":0.006263,"FiveDayReturnAfter":0.007259,"FiveDayReturnBefore":0.006256},{"Ticker":"NOV","EffectiveDate":"2013-09-11","Type":"Dividend","Title":"The Firm pays dividend $0.23445","DailyReturn":0.004594,"FiveDayReturnAfter":0.00674,"FiveDayReturnBefore":0.038239},{"Ticker":"NOV","EffectiveDate":"2013-09-10","Type":"RatingUpgrade","Title":"Credit Suisse upgrades NOV to Outperform from Neutral. Target Price is $90; previously $82.","DailyReturn":0.002678,"FiveDayReturnAfter":0.007257,"FiveDayReturnBefore":0.053968},{"Ticker":"NOV","EffectiveDate":"2013-09-10","Type":"RatingUpgrade","Title":"Credit Suisse upgrades NOV to Outperform from Neutral.","DailyReturn":0.002678,"FiveDayReturnAfter":0.007257,"FiveDayReturnBefore":0.053968},{"Ticker":"NOV","EffectiveDate":"2013-09-09","Type":"RatingNeutral","Title":"Standpoint Research downgrades NOV to Hold from Buy.","DailyReturn":0.005256,"FiveDayReturnAfter":0.006256,"FiveDayReturnBefore":0.048322},{"Ticker":"NOV","EffectiveDate":"2013-08-15","Type":"RatingUpgrade","Title":"RBC Capital upgrades NOV to Outperform from Sector Perform. Target Price is $86; previously $78.","DailyReturn":0.002997,"FiveDayReturnAfter":-0.037903,"FiveDayReturnBefore":0.012888},{"Ticker":"NOV","EffectiveDate":"2013-07-31","Type":"RatingNeutral","Title":"Societe Generale downgrades NOV to Hold from Buy. Target Price is $77; previously $83.","DailyReturn":0.011095,"FiveDayReturnAfter":0.037891,"FiveDayReturnBefore":-0.047005},{"Ticker":"NOV","EffectiveDate":"2013-07-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.024459,"FiveDayReturnAfter":0.010905,"FiveDayReturnBefore":-0.034946},{"Ticker":"NOV","EffectiveDate":"2013-07-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.024459,"FiveDayReturnAfter":0.010905,"FiveDayReturnBefore":-0.034946},{"Ticker":"NOV","EffectiveDate":"2013-06-12","Type":"Dividend","Title":"The Firm pays dividend $0.23445","DailyReturn":0.004354,"FiveDayReturnAfter":0.036756,"FiveDayReturnBefore":-0.010497},{"Ticker":"NOV","EffectiveDate":"2013-05-22","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.01789,"FiveDayReturnAfter":0.016056,"FiveDayReturnBefore":0.034523},{"Ticker":"NOV","EffectiveDate":"2013-04-29","Type":"RatingNeutral","Title":"BMO Capital maintains NOV to Outperform. Target Price is $88; previously $90.","DailyReturn":-0.006031,"FiveDayReturnAfter":0.008409,"FiveDayReturnBefore":0.030777},{"Ticker":"NOV","EffectiveDate":"2013-04-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.006031,"FiveDayReturnAfter":0.008409,"FiveDayReturnBefore":0.030777},{"Ticker":"NOV","EffectiveDate":"2013-04-29","Type":"RatingNeutral","Title":"Cowen & Co. maintains NOV to Buy. Target Price is $90; previously $95.","DailyReturn":-0.006031,"FiveDayReturnAfter":0.008409,"FiveDayReturnBefore":0.030777},{"Ticker":"NOV","EffectiveDate":"2013-04-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.006031,"FiveDayReturnAfter":0.008409,"FiveDayReturnBefore":0.030777},{"Ticker":"NOV","EffectiveDate":"2013-04-26","Type":"EarningsRevenueMiss","Title":"Before market open, NOV reports 2013 Q1's earning $1.29 per share and revenue $5310MM. This misses analyst's estimated EPS $1.37, misses estimated revenue $5390MM.","DailyReturn":-0.013242,"FiveDayReturnAfter":-0.024093,"FiveDayReturnBefore":0.039453},{"Ticker":"NOV","EffectiveDate":"2013-04-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.013242,"FiveDayReturnAfter":-0.024093,"FiveDayReturnBefore":0.039453},{"Ticker":"NOV","EffectiveDate":"2013-04-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.013242,"FiveDayReturnAfter":-0.024093,"FiveDayReturnBefore":0.039453},{"Ticker":"NOV","EffectiveDate":"2013-03-22","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.006636,"FiveDayReturnAfter":0.042444,"FiveDayReturnBefore":-0.014348},{"Ticker":"NOV","EffectiveDate":"2013-03-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.006636,"FiveDayReturnAfter":0.042444,"FiveDayReturnBefore":-0.014348},{"Ticker":"NOV","EffectiveDate":"2013-03-20","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Buy. Target Price is $85; previously $96.","DailyReturn":0.010437,"FiveDayReturnAfter":0.020947,"FiveDayReturnBefore":0.00782},{"Ticker":"NOV","EffectiveDate":"2013-03-13","Type":"Dividend","Title":"The Firm pays dividend $0.11722","DailyReturn":0.000296,"FiveDayReturnAfter":0.00782,"FiveDayReturnBefore":0.008911},{"Ticker":"NOV","EffectiveDate":"2013-02-05","Type":"RatingNeutral","Title":"Bernstein downgrades NOV to Market Perform from Outperform. Target Price is $80; previously $85.","DailyReturn":-0.027932,"FiveDayReturnAfter":-0.027597,"FiveDayReturnBefore":-0.047995},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Dahlman Rose maintains NOV to Buy. Target Price is $95; previously $102.","DailyReturn":-0.015296,"FiveDayReturnAfter":-0.03107,"FiveDayReturnBefore":-0.037729},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"RS Platou Markets maintains NOV to Buy. Target Price is $87; previously $96.","DailyReturn":-0.015296,"FiveDayReturnAfter":-0.03107,"FiveDayReturnBefore":-0.037729},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"BMO Capital maintains NOV to Outperform. Target Price is $90; previously $101.","DailyReturn":-0.015296,"FiveDayReturnAfter":-0.03107,"FiveDayReturnBefore":-0.037729},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Buy. Target Price is $86; previously $90.","DailyReturn":-0.015296,"FiveDayReturnAfter":-0.03107,"FiveDayReturnBefore":-0.037729},{"Ticker":"NOV","EffectiveDate":"2013-02-04","Type":"RatingNeutral","Title":"Barclays maintains NOV to Overweight. Target Price is $93; previously $126.","DailyReturn":-0.015296,"FiveDayReturnAfter":-0.03107,"FiveDayReturnBefore":-0.037729},{"Ticker":"NOV","EffectiveDate":"2013-02-01","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on NOV to Neutral. Target Price is $72.","DailyReturn":-0.038845,"FiveDayReturnAfter":-0.084978,"FiveDayReturnBefore":0.00514},{"Ticker":"NOV","EffectiveDate":"2013-02-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.038845,"FiveDayReturnAfter":-0.084978,"FiveDayReturnBefore":0.00514},{"Ticker":"NOV","EffectiveDate":"2013-02-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.038845,"FiveDayReturnAfter":-0.084978,"FiveDayReturnBefore":0.00514},{"Ticker":"NOV","EffectiveDate":"2013-01-25","Type":"RatingNeutral","Title":"ISI Group downgrades NOV to Buy from Strong Buy. Target Price is $83; previously $105.","DailyReturn":0.003254,"FiveDayReturnAfter":0.00514,"FiveDayReturnBefore":0.04634},{"Ticker":"NOV","EffectiveDate":"2013-01-08","Type":"RatingNeutral","Title":"RBC Capital downgrades NOV to Sector Perform from Outperform.","DailyReturn":-0.02733,"FiveDayReturnAfter":-0.014256,"FiveDayReturnBefore":0.079761},{"Ticker":"NOV","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"Guggenheim downgrades NOV to Neutral from Buy. Target Price is $71; previously $90.","DailyReturn":-0.010827,"FiveDayReturnAfter":0.058631,"FiveDayReturnBefore":-0.037118},{"Ticker":"NOV","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"Guggenheim downgrades NOV to Neutral from Buy.","DailyReturn":-0.010827,"FiveDayReturnAfter":0.058631,"FiveDayReturnBefore":-0.037118},{"Ticker":"NOV","EffectiveDate":"2012-12-12","Type":"RatingNeutral","Title":"Credit Agricole downgrades NOV to Outperform from Buy. Target Price is $80; previously $95.","DailyReturn":-0.022209,"FiveDayReturnAfter":0.010535,"FiveDayReturnBefore":-0.009805},{"Ticker":"NOV","EffectiveDate":"2012-12-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.008016,"FiveDayReturnAfter":-0.031536,"FiveDayReturnBefore":-0.020733},{"Ticker":"NOV","EffectiveDate":"2012-12-06","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.008016,"FiveDayReturnAfter":-0.031536,"FiveDayReturnBefore":-0.020733},{"Ticker":"NOV","EffectiveDate":"2012-12-05","Type":"Dividend","Title":"The Firm pays dividend $0.11722","DailyReturn":-0.000728,"FiveDayReturnAfter":-0.009805,"FiveDayReturnBefore":-0.017723},{"Ticker":"NOV","EffectiveDate":"2012-11-16","Type":"RatingUpgrade","Title":"Standpoint Research upgrades NOV to Buy from Hold.","DailyReturn":0.002413,"FiveDayReturnAfter":0.030202,"FiveDayReturnBefore":0.013722},{"Ticker":"NOV","EffectiveDate":"2012-11-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.012796,"FiveDayReturnAfter":0.029048,"FiveDayReturnBefore":-0.022042},{"Ticker":"NOV","EffectiveDate":"2012-11-15","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.012796,"FiveDayReturnAfter":0.029048,"FiveDayReturnBefore":-0.022042},{"Ticker":"NOV","EffectiveDate":"2012-10-31","Type":"RatingNeutral","Title":"JP Morgan maintains NOV to Overweight. Target Price is $95; previously $103.","DailyReturn":-0.011667,"FiveDayReturnAfter":-0.021552,"FiveDayReturnBefore":-0.079},{"Ticker":"NOV","EffectiveDate":"2012-10-26","Type":"RatingNeutral","Title":"Jefferies maintains NOV to Buy. Target Price is $90; previously $94.","DailyReturn":-0.00414,"FiveDayReturnAfter":-0.044373,"FiveDayReturnBefore":-0.091198},{"Ticker":"NOV","EffectiveDate":"2012-10-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.024619,"FiveDayReturnAfter":-0.069021,"FiveDayReturnBefore":-0.056225},{"Ticker":"NOV","EffectiveDate":"2012-10-25","Type":"EarningsRelease","Title":"Before market open, NOV reports 2012 Q3's earning $1.44 per share and revenue $5319MM..","DailyReturn":-0.024619,"FiveDayReturnAfter":-0.069021,"FiveDayReturnBefore":-0.056225},{"Ticker":"NOV","EffectiveDate":"2012-10-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.024619,"FiveDayReturnAfter":-0.069021,"FiveDayReturnBefore":-0.056225},{"Ticker":"NOV","EffectiveDate":"2012-10-04","Type":"RatingNeutral","Title":"Societe Generale maintains NOV to Buy. Target Price is $93; previously $86.","DailyReturn":0.010693,"FiveDayReturnAfter":-0.015212,"FiveDayReturnBefore":0.014065},{"Ticker":"NOV","EffectiveDate":"2012-10-03","Type":"RatingNeutral","Title":"Goldman Sachs assumes NOV to Buy. Target Price is $97.","DailyReturn":-0.01536,"FiveDayReturnAfter":-0.00796,"FiveDayReturnBefore":0.006713},{"Ticker":"NOV","EffectiveDate":"2012-09-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000374,"FiveDayReturnAfter":0.002494,"FiveDayReturnBefore":-0.005724},{"Ticker":"NOV","EffectiveDate":"2012-09-28","Type":"Item_1.02","Title":"Termination of a Material Definitive Agreement\r\n","DailyReturn":-0.000374,"FiveDayReturnAfter":0.002494,"FiveDayReturnBefore":-0.005724},{"Ticker":"NOV","EffectiveDate":"2012-09-28","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.000374,"FiveDayReturnAfter":0.002494,"FiveDayReturnBefore":-0.005724},{"Ticker":"NOV","EffectiveDate":"2012-09-12","Type":"Dividend","Title":"The Firm pays dividend $0.10821","DailyReturn":0.006626,"FiveDayReturnAfter":-0.003016,"FiveDayReturnBefore":0.062801},{"Ticker":"NOV","EffectiveDate":"2012-09-07","Type":"RatingNeutral","Title":"RS Platou Markets maintains NOV to Buy. Target Price is $105; previously $100.","DailyReturn":0.02837,"FiveDayReturnAfter":0.059126,"FiveDayReturnBefore":0.032018},{"Ticker":"NOV","EffectiveDate":"2012-07-30","Type":"RatingNeutral","Title":"Dahlman Rose maintains NOV to Buy. Target Price is $105; previously $103.","DailyReturn":0.005159,"FiveDayReturnAfter":0.022816,"FiveDayReturnBefore":0.062315},{"Ticker":"NOV","EffectiveDate":"2012-07-27","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Buy. Target Price is $96; previously $90.","DailyReturn":0.004774,"FiveDayReturnAfter":-0.007806,"FiveDayReturnBefore":0.03951},{"Ticker":"NOV","EffectiveDate":"2012-07-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.088816,"FiveDayReturnAfter":0.090397,"FiveDayReturnBefore":-0.024646},{"Ticker":"NOV","EffectiveDate":"2012-07-26","Type":"RatingNeutral","Title":"Standpoint Research downgrades NOV to Hold from Buy.","DailyReturn":0.088816,"FiveDayReturnAfter":0.090397,"FiveDayReturnBefore":-0.024646},{"Ticker":"NOV","EffectiveDate":"2012-07-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.088816,"FiveDayReturnAfter":0.090397,"FiveDayReturnBefore":-0.024646},{"Ticker":"NOV","EffectiveDate":"2012-07-26","Type":"EarningsRelease","Title":"Before market open, NOV reports 2012 Q2's earning $1.42 per share and revenue $4734MM..","DailyReturn":0.088816,"FiveDayReturnAfter":0.090397,"FiveDayReturnBefore":-0.024646},{"Ticker":"NOV","EffectiveDate":"2012-06-13","Type":"Dividend","Title":"The Firm pays dividend $0.10821","DailyReturn":-0.009281,"FiveDayReturnAfter":-0.001647,"FiveDayReturnBefore":0.018551},{"Ticker":"NOV","EffectiveDate":"2012-05-24","Type":"RatingUpgrade","Title":"Societe Generale upgrades NOV to Buy from Hold. Target Price is $85; previously $92.","DailyReturn":-0.001472,"FiveDayReturnAfter":-0.017818,"FiveDayReturnBefore":0.065843},{"Ticker":"NOV","EffectiveDate":"2012-05-16","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.023634,"FiveDayReturnAfter":0.023808,"FiveDayReturnBefore":-0.060732},{"Ticker":"NOV","EffectiveDate":"2012-05-16","Type":"RatingUpgrade","Title":"Standpoint Research upgrades NOV to Buy from Hold.","DailyReturn":-0.023634,"FiveDayReturnAfter":0.023808,"FiveDayReturnBefore":-0.060732},{"Ticker":"NOV","EffectiveDate":"2012-04-26","Type":"RatingNeutral","Title":"Citigroup maintains NOV to Buy. Target Price is $95; previously $91.","DailyReturn":-0.001172,"FiveDayReturnAfter":-0.033486,"FiveDayReturnBefore":-0.028233},{"Ticker":"NOV","EffectiveDate":"2012-04-26","Type":"RatingNeutral","Title":"RS Platou Markets maintains NOV to Buy. Target Price is $98; previously $100.","DailyReturn":-0.001172,"FiveDayReturnAfter":-0.033486,"FiveDayReturnBefore":-0.028233},{"Ticker":"NOV","EffectiveDate":"2012-04-25","Type":"EarningsRelease","Title":"Before market open, NOV reports 2012 Q1's earning $1.42 per share and revenue $4303MM..","DailyReturn":-0.015252,"FiveDayReturnAfter":-0.034027,"FiveDayReturnBefore":-0.019044},{"Ticker":"NOV","EffectiveDate":"2012-04-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.015252,"FiveDayReturnAfter":-0.034027,"FiveDayReturnBefore":-0.019044},{"Ticker":"NOV","EffectiveDate":"2012-04-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.015252,"FiveDayReturnAfter":-0.034027,"FiveDayReturnBefore":-0.019044},{"Ticker":"NOV","EffectiveDate":"2012-03-14","Type":"Dividend","Title":"The Firm pays dividend $0.10821","DailyReturn":-0.019207,"FiveDayReturnAfter":0.001468,"FiveDayReturnBefore":0.054216},{"Ticker":"NOV","EffectiveDate":"2012-02-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.009308,"FiveDayReturnAfter":0.016921,"FiveDayReturnBefore":0.013697},{"Ticker":"NOV","EffectiveDate":"2012-02-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.009308,"FiveDayReturnAfter":0.016921,"FiveDayReturnBefore":0.013697}];